• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    (CSE:DMED)

    0.0950 UNCHANGED
    Streaming Delayed Price Updated: 3:59 PM EDT, Oct 30, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 0.0950
    Bid (Size) 0.1000 (10,500)
    Ask (Size) 0.1000 (54,500)
    Prev. Close 0.0950
    Today's Range 0.0950 - 0.0950
    52wk Range 0.0150 - 0.1400
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    DiagnaMed and QIMC Confirm Major Expansion of Hydrogen Zone by Over 11 Kilometers in Ontario's Temiscamingue Graben
    Toronto, Ontario--(Newsfile Corp. - October 27, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or "DMED" or the... 
    Via Newsfile
    Topics Artificial Intelligence
    DiagnaMed and QIMC Confirm Major Discovery of Widespread Natural Hydrogen System in Ontario's Temiscamingue Graben
    209 of 456 Soil Samples Exceed 500 ppm Hydrogen (H2), Including Multiple Readings Over 2,000 ppm - A Major Step... 
    Via Newsfile
    Topics Artificial Intelligence

    Performance

    YTD
    +171.4%
    +171.4%
    1 Month
    -9.5%
    -9.5%
    3 Month
    +58.3%
    +58.3%
    6 Month
    +280.0%
    +280.0%
    1 Year
    +375.0%
    +375.0%

    More News

    Read More
    DiagnaMed Holdings Corp. and Quebec Innovative Materials Corp. Sign Memorandum of Understanding with Temiscamingue First Nation to Advance Natural Hydrogen Development Along the Ontario-Quebec Hydrogen Corridor
    Via Newsfile
    DiagnaMed Strengthens Leadership Team and Confirms Completion of Extensive Hydrogen Soil Sampling Program in Ontario's Temiscamingue Graben
    Via Newsfile
    Topics Climate Change
    DiagnaMed Congratulates QIMC on Quebec Drill Permit Approval and Announces Significant Progress on Ontario Clean Natural Hydrogen Soil Sampling Program
    Via Newsfile
    DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants
    Via Newsfile
    DiagnaMed Announces Chief Financial Officer Transition
    Via Newsfile
    DiagnaMed Launches Ontario Hydrogen Exploration Campaign in Conjunction with QIMC and INRS; Strengthens Board
    Via Newsfile
    DiagnaMed Advances Ontario Natural Hydrogen & Helium Program with Strategic Geological Targeting in Timiskaming Graben
    Via Newsfile
    DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in Ontario
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    DiagnaMed Expands Clean Hydrogen Energy Extraction Capabilities to Demonstrate Proof of Concept of Proprietary Technology
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    DiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen District
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program
    From Revive Therapeutics Ltd.
    Via GlobeNewswire
    DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
    Via Newsfile
    Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program
    From Revive Therapeutics Ltd.
    Via GlobeNewswire
    DiagnaMed Announces LIFE Offering of up to $510,000
    Via Newsfile
    Topics Artificial Intelligence
    DiagnaMed To Support Quebec's Hydrogen Ambitions Through its Collaboration with QIMC
    Via Newsfile
    Topics Emissions
    DiagnaMed Advances Hydrogen Energy Technology Innovation
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    DiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen Production
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    DiagnaMed Announces Resignation of Director and Grant of Stock Options
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    DiagnaMed Partners with Texas Tech University to Pioneer Hydrogen Innovation
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    DiagnaMed and EIREX Collaborate to Develop and Commercialize Novel Modular Technology Producing Hydrogen from Water
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    DiagnaMed Announces Stock Option Grants and Shares for Debt Settlement
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire
    DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen
    From DiagnaMed Holdings Corp.
    Via GlobeNewswire

    Frequently Asked Questions

    Is DMED publicly traded?
    Yes, DMED is publicly traded.
    What exchange does DMED trade on?
    DMED trades on the Canadian Securities Exchange
    What is the ticker symbol for DMED?
    The ticker symbol for DMED is DMED on the Canadian Securities Exchange
    What is the current price of DMED?
    The current price of DMED is 0.0950
    When was DMED last traded?
    The last trade of DMED was at 10/30/25 03:59 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.